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Abstract 
Churg-Strauss syndrome (CSS) or allergic granulomatosis is a necrotizing 
vasculitis with different presentations. In this case highlights the anesthetic 
management of a known case of CSS who underwent posterior spinal fixation 
surgery. Our patient fulfilled the ACR diagnosis criteria because of  showing 
asthma, paranasal sinusitis, positive skin biopsy and eosinophilia.Before 
anesthesia induction, laryngeal nerves block by lidocaine was conducted. 
Fiber-optic bronchoscopy was preceded by inserting a No. 7.5 spiral cuffed 
endotracheal tube. 
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Introduction 
Churg-Strauss syndrome (CSS) or allergic 
granulomatosis is a necrotizing vasculitis that causes 
multi-organ damages such as sinusitis, nasal polyps, 
pulmonary infiltrations, degenerative interstitial lung 
disease, cutaneous nodules and rashes, 
glomerulonephritis, coronary vasculitis, endocarditis, 
congestive heart failure, optic neuritis, subarachnoid 
hemorrhage, cerebral infarcts, asthma and vertebral 
schwannoma (1-4). Jacobe Churg and Lotte Strauss 
identified CSS at 1951. Diagnosis of CSS involves 
clinical symptoms along with pathologic findings in 
biopsy (1). CSS is an uncommon coexisting disease 
and could be a challenge for anesthesiologists (5-9). 
Following case highlights the anesthetic management 
of a known case of CSS who underwent posterior 
spinal fixation surgery. 
Case Report 
A 70 kg, 60-year man admitted in Loghman 
Hospital, Shahid Beheshti University of Medical 
Sciences, Tehran, Iran, which complained of radicular 
pain in hands and reduction of muscular force with 
diagnosis of cervical disc herniation requiring 
laminectomy. He has suffered from CSS for 14 years. 
His presentations include asthma and recurrent 
sinusitis. He has been treated with bronchodilator 
(Salmetrol 2puffs every 12 hours) since diagnosis. 
Sinusitis was treated using co-amoxiclav 625mg every 
8 hours for one month. On admission, symptoms were 
controlled. Preoperative assessments showed he was 
stable and conscious. Lungs were clear, and there was 
no evidence of productive cough.  
Pulmonary function test (PFT) result was 
normal, Chest X-Ray showed evidence of mild pleural 
effusion (PE) in the right side. Echocardiography 
reported ejection fraction (EF)=55% and mild aortic 
insufficiency (AI), no evidence of cardiomyopathy was 
present. Cardiac consult evaluated the operation as 
moderate risk. Electrocardiogram showed normal 
sinus rhythm and rate. Preoperative laboratory data 
were in normal range. 
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Patient drug history was as follow: Azathioprine 
75mg/day, Alendronate 40mg/week, Omeprazole 
40mg/day, Serotide spray, Gabapentin 100mg/day, 
Prednisolone 10mg/day.  
For the purpose of operation preparation, in 
preoperation visit, it ordered to continue drugs until to 
operation day. In the morning of surgery, usual dose of 
prednisolone and 4 puffs of salbutamol inhalation were 
administered to the patient. 
Before anesthesia induction, anterior part of 
cervical collar removed whilst neck stabilization by 
posterior part of collar assured, laryngeal nerves block 
by lidocaine conducted. Fiber-optic bronchoscopy 
preceded by inserting a No. 7.5 spiral cuffed 
endotracheal tube. After confirming placement of the 
tube by capnography (ETCO2), it fixed by adhesive 
tapes. Here upon, anesthesia induced using propofol 
140 mg, fentanyl 150 μg, and lidocaine 100 mg. We 
used 6mg of cisatracurium as the muscle relaxant. In 
order to monitor blood pressure during operation, 
arterial line catheter placed. The patient connected to 
anesthetic machine, the anterior part of cervical collar 
fixed, and the patient position changed to prone with 
proper considerations. 
During operation, anesthesia maintained with 
1.2% isoflurane and intravenous remifentanil infusion 
0.3μg/ kg /min. Primary arterial blood gas (ABG) 
analysis was in normal range. During 2.5 hours of the 
operation, 2mg cisatracurium injected for the 
relaxation purpose twice. At the end of the surgical 
procedure, the patient turned back to the supine 
position and remifentanil infusion ceased. 
Combination of neostigmine 4 mg and atropine 1.5 mg 
was administered to reverse remaining muscle relaxant 
effects, when the patient regained efficient 
spontaneous volume and rate of breathing. 
Discussion 
CSS is an important fibrinoid necrotizing 
inflammatory leukocytoclastic systemic small-vessel 
vasculitis that is associated with perinuclear pattern 
ANCA (10, 11).  
Pathophysiology of CSS is not well understood, 
particularly triggering circumstances (12). In their 
original description of ANCAs, Daives and associates 
suggested that arbovirus infection-related 
superantigens might stimulate the production of 
ANCAs because of molecular mimicry or some other 
abnormality of immune tolerance. Triggering of these 
vasculitides by infection has remained a 
pathophysiological consideration (13).  
Cytokines undoubtedly participate in this 
autoimmune process. Patients with CSS have markedly 
increased serum levels of interferon alpha and 
interleukin two (IL-2) and moderate increases of 
tumour necrosis factor alpha (TNF-α) and IL-1β 
similar to those observed in polyarthritis nodosa 
(PAN). Elevations of serum IL-6 concentrations have 
been shown to precede a rise in serum rheumatoid 
factors that may accompany the onset of an 
exacerbation of CSS. Thus, IL-6 may be an important 
triggering factor. The rheumatoid factors are chiefly of 
IgG and immunoglobulin M (IgM) classes, rather than 
immunoglobulin A (IgA) or IgE (14). 
The American college of rheumatology (ACR), 
offered 6 criteria that the patient should have at least 4 
of them for CSS diagnosis with the sensitivity of 85% 
and specificity of 99.7%; including; asthma, 
eosinophilia, mononeuropathy, pulmonary infiltration 
in chest X ray, paranasal sinus abnormalities and a 
biopsy containing a blood vessel with extravascular 
eosinophils (15).  
Our patient fulfilled ACR diagnosis criteria 
because of showed asthma, paranasal sinusitis, positive 
skin biopsy and eosinophilia. Most patients with CSS 
have asthma; therefore, pulmonary function tests 
(PFTs) are essential in preoperative evaluation. In our 
case, the PFT (as described above) was not severely 
affected by asthma.  
Patients with CSS usually taking corticosteroid 
in their medication, therefore it is important for 
anesthesiologists to manage corticosteroid level of 
CSS patients to compensate potential adrenal 
insufficiency (16). The patient took 10mg oral 
prednisolone per day, hence additional usage 
supplemental corticosteroids did not need.  
We also used propofol for induction because 
its benefits in asthmatic patients due to its 
bronchodilation effects. 
Volatile anesthetics possess bronchodilatory 
effects airway responsiveness and attenuate histamine-
mediated bronchospasm. The mechanism is thought to 
be β-adrenergic receptor stimulation leading to 
increased cyclic adenosine mono phosphate (cAMP). 
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Increased cAMP may bind free calcium within 
bronchial myoplasmand cause relaxation by negative 
feedback. All these confirmed the beneficial effects of 
volatiles for the maintenance of anesthesia in the 
patients with hyperreactive airway. Desflurane is an 
exception, which leads to increased secretions, 
coughing, laryngospasm and bronchospasm, unlike the 
other ones. On the other hand analysis of the 
respiratory mechanics and lung histology in rats which 
anesthetized with sevoflurane showed evoked stiffness 
of lung tissue and increased mechanical inhomogeneity 
(17). Takala et al. measured pulmonary inflammatory 
mediators in bronchoalveolar lavage fluid after 
sevoflurane anesthesia in pigs and reported that 
sevoflurane increased pulmonary leukotriene C4, NO3- 
and NO2 production that leads to inflammatory 
response (18). 
Conclusion 
Churg-Strauss syndrome mandates an 
experienced and skilled team working together with 
appropriate devices in the perioperative period; if the 
airway management is going to be successful. 
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